Effective cholesterol management is an important factor in reducing cardiovascular (CV) risks in patients with diabetes, coronary heart disease and following myocardial infarction (MI)2-3. When reducing CV risk, drug treatments like statins are only part of the solution. With decades of expertise in cardio-metabolic health, Abbott offers a range of supporting treatments for patients with dyslipidemia, to help people lead healthier lives.
The information in this section is intended only for healthcare professionals of Pakistan. If you are a healthcare professional, click "I Agree" to continue.